Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
about
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron diseaseRiluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?Prognostic factors in ALS: A critical reviewSurvey of ALS-associated factors potentially promoting Ca2+ overload of motor neurons.Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis.Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyTimelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)--a 20-year review: can we do better?EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis.Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study.Prognostic factors and survival of ALS patients from Belgrade, Serbia.The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: A population based study in Modena, Italy
P2860
Q24201081-73014CE7-C8AE-421A-96C0-C19E4CE4C57FQ24234807-6A38A96B-5050-4D97-836A-C41F5F04F1A4Q24246517-EE9F29ED-CCE7-4CDC-96B5-FC1A58259F1CQ34104378-93FEDBCA-4146-48B7-890E-4DDC9C521693Q36447824-9A0BD546-EBA3-46C3-A7F5-09A357290E23Q36961660-A143CBBC-ECD4-4827-9B7F-E7FE07CF1FBFQ37272856-61EFDB56-0EB4-4137-9EC9-032B8CD29923Q37613342-ED0A87D4-CB5D-40E8-A711-B6DC6F9B1636Q37766606-E5C46635-FA05-4736-948E-63BEB12667FEQ37931374-B774286D-5A6A-4766-BA43-2A568D4C36A6Q37981224-C8B5AFEC-93A6-4E35-8B7B-3FD36B939934Q38091029-BFBBEA2B-024A-43D2-8209-4FC572280851Q38693732-E91C969E-4D0D-42B6-9483-0FB18ACB1E25Q40385575-DE887D28-E00E-4C57-8BBE-F52428118EEDQ51312004-E7FA9823-52E9-49D2-8BF8-B6F4DE2C9341Q58244127-4A8F5C2D-3C1E-4CE1-BC77-749B6C0FE9A6
P2860
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
@ast
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
@en
type
label
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
@ast
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
@en
prefLabel
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
@ast
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
@en
P2860
P1476
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole
@en
P2093
J Douglas Mitchell
Miland Joshi
P2860
P356
10.1080/14660820500396984
P577
2006-06-01T00:00:00Z